Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Jelkmann

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Opinion in Nephrology and Hypertension|May 31, 2018
Activin receptor ligand traps in chronic kidney diseaseWolfgang Jelkmann
European Journal of Haematology|January 27, 2007
Erythropoietin after a century of research: younger than everWolfgang Jelkmann
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 26, 2013
Physiology and pharmacology of erythropoietinWolfgang Jelkmann
Expert Opinion on Biological Therapy|April 5, 2012
Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatmentsWolfgang Jelkmann
The Journal of Physiology|November 17, 2010
Regulation of erythropoietin productionWolfgang Jelkmann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2014
The ESA scenario gets complex: from biosimilar epoetins to activin trapsWolfgang Jelkmann
Methods in Enzymology|November 14, 2007
Control of erythropoietin gene expression and its use in medicineWolfgang Jelkmann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
Recombinant EPO production--points the nephrologist should knowWolfgang Jelkmann
Frontiers of Hormone Research|June 28, 2016
ErythropoietinWolfgang Jelkmann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2012
The elusive erythropoietin receptorWolfgang Jelkmann
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Opinion in Nephrology and Hypertension|May 31, 2018
Activin receptor ligand traps in chronic kidney diseaseWolfgang Jelkmann
European Journal of Haematology|January 27, 2007
Erythropoietin after a century of research: younger than everWolfgang Jelkmann
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 26, 2013
Physiology and pharmacology of erythropoietinWolfgang Jelkmann
Expert Opinion on Biological Therapy|April 5, 2012
Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatmentsWolfgang Jelkmann
The Journal of Physiology|November 17, 2010
Regulation of erythropoietin productionWolfgang Jelkmann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2014
The ESA scenario gets complex: from biosimilar epoetins to activin trapsWolfgang Jelkmann
Methods in Enzymology|November 14, 2007
Control of erythropoietin gene expression and its use in medicineWolfgang Jelkmann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
Recombinant EPO production--points the nephrologist should knowWolfgang Jelkmann
Frontiers of Hormone Research|June 28, 2016
ErythropoietinWolfgang Jelkmann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2012
The elusive erythropoietin receptorWolfgang Jelkmann
Pageof 7